Navigation Links
Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
Date:4/21/2008

ng: general economic and business conditions, both nationally and in the regions in which we operate; market demand; technological changes that could impact our existing products or our ability to develop and commercialize future products; competition; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; adverse results or unexpected delays in drug discovery and clinical development processes; decisions, and the timing of decisions, made by health regulatory agencies regarding approval of our technology and products; the requirement for substantial funding to conduct research and development and to expand commercialization activities or consummate acquisitions; the accuracy of our estimations of the size of the market, and the potential market, for our products in specific disease areas; sales numbers and future guidance publicly provided by Boston Scientific Corporation regarding sales of their paclitaxel-eluting coronary stent products; and any other factors that may affect performance. In addition, our business is subject to certain operating risks that may cause the actual results expressed or implied by the forward-looking statements in this report to differ materially from our actual results. These operating risks include: our ability to attract and retain qualified personnel; our ability to successfully complete preclinical and clinical development of our products; changes in business strategy or development plans; our failure to obtain patent protection for discoveries; loss of patent protection resulting from third party challenges to our patents; commercialization limitations imposed by patents owned or controlled by third parties; our ability to obtain rights to technology from licensors; liability for patent claims and other claims asserted against us; our ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; the ability to enter into,
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
2. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
3. Angiotech announces director resignation
4. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
5. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
6. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
7. Angiotech to participate in Lehman Brothers Healthcare Conference
8. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
9. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
10. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
11. Angiotech announces results for the fourth quarter ended December 31, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... be valued at $5.6 billion in 2019. It ... 18.1% from 2013 to 2019, and was valued ... research report published by Transparency Market Research. , ... please visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research ...
(Date:8/29/2014)... 29, 2014 Pittcon is pleased to ... colleague Koichiro Matsuda, Horiba Scientific, have organized a session ... 2014. JASIS , Asia’s largest analytical and scientific ... Makuhari Messe, Japan. , The four speakers in ... from Single Molecules to Single Cells” will present their ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
(Date:8/29/2014)... Boston, MA (PRWEB) August 29, 2014 Due ... (FRC) last week, the Adult Stem Cell Technology Center, ... donations to support stem cell therapy research that might benefit ... adult stem cells for new stem cell technologies and therapeutic ... ALS Ice Bucket Challenge donors who wish not ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... from Stevens Institute of Technology, consisting of undergraduate ... Jing, Xi Chen, and Zhenbo Fu and led ... Shi from the Department of Mechanical Engineering, placed ... Institute of Standards and Technology (NIST) Mobile Microrobotics ...
... and MARCY L,ETOILE, France , May 21 ... have entered into a partnership to commercialize a mass ... will work with Shimadzu and their subsidiary, Kratos Analytical, ... optimized integration into the microbiology laboratory workflow. This new ...
... /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE YMI, TSX:YM), today announced ... results from several global nimotuzumab trials in adults with Glioblastoma ... the American Society of Clinical Oncology annual meeting held from ... The trials are being conducted by Oncoscience AG (Wedel, ...
Cached Biology Technology:Stevens team places third in 2010 IEEE/NIST Mobile Microrobotics Challenge 2Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology 2Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology 3Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology 4YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 2YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 3YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 4YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 5
(Date:8/28/2014)... the developmental on-off switch for Streptomyces , a ... of the world,s naturally derived antibiotic medicines. , ... is possible to manipulate this switch to make nature,s ... August 28 in Cell , found that a ... a larger protein called BldD ultimately controls whether a ...
(Date:8/28/2014)... 2014A new method for measuring and imaging how quickly ... researchers better understand how drug abuse affects the brain, ... engineering, and lead to better treatment options for recovering ... of researchers from Stony Brook University in New York, ... published today in The Optical Society,s (OSA) open-access journal ...
(Date:8/28/2014)... Broeker, the first person to alert the world to ... to be captured and stored underground. He says that ... is the best way to avoid global warming getting ... Broeker (Columbia University, New York) made the call during ... Iceland, where 150 scientists are meeting to discuss Carbon ...
Breaking Biology News(10 mins):Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3Global warming pioneer calls for CO2 to be taken from atmosphere and stored underground 2
... is pleased to announce the recipients of its 2010 ... at the Society,s 54th Annual Meeting on Monday, February ... in San Francisco, California. The awardees are: ... and ,Harvard Medical School will receive the Anatrace Membrane ...
... This release is available in German . ... and maintenance of the Earth,s multi-trillion dollar ecosystems - from ... have a key role in countering climate change and climate-proofing ... a new climate issues update by The Economics of Ecosystems ...
... widely recognized for his expertise in the identification and ... recipient of the Charles River Laboratories, Excellence in Refinement ... at the 7th World Congress on Alternatives and Animal ... by Charles River Laboratories, in cooperation with the Johns ...
Cached Biology News:Biophysical Society names 2010 award recipients 2Time to tap climate change-combating potential of the world's ecosystems 2Time to tap climate change-combating potential of the world's ecosystems 3Time to tap climate change-combating potential of the world's ecosystems 4Time to tap climate change-combating potential of the world's ecosystems 5
... Features hardwall acrylic panels mounted ... to form a free-standing modular ... Class 10/ISO 3. Optional ceiling ... ionizers are configured to customer ...
... highly sensitive reagent for the detection of ... form of recombinant E. coli phosphate-binding protein ... sensitive to changes in its environment.How it ... is rapid and tight (Kd ~ 0.1 ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
... These versatile enclosures are ... nitrogen or other process ... low-humidity environment. HEPA filtration, ... ionization modules also available, ...
Biology Products: